HCL Technologies, a leading global IT services company, today announced that it has been recognized as a life sciences IT outsourcing Leader and a “star performer” by the leading advisory and research firm Everest Group in its report for IT Outsourcing in Life Sciences Industry Service Provider Landscape with PEAK Matrix™ Assessment 2015 report.
The award acknowledges HCL’s continued growth and market success, exceptional delivery capabilities and for its significant investment in proprietary life science solutions. The company consistently secured large, transformational IT outsourcing (ITO) deals by providing a complete range of services including clinical supply management, research and development, supply chain, sales and marketing, internal enterprise IT, lab information management systems (LIMS) and compliance management.
The Everest Group report analyzes the capabilities of twenty leading ITO service providers as they relate to the global life sciences sector. It maps each provider on its Performance, Experience, Ability and Knowledge (PEAK) Matrix™, a composite index of a range of distinct metrics related to providers’ capabilities and market success across two key dimensions. The report measures market success by the number, scale and growth of large life sciences’ ITO contracts, and ranks delivery capabilities by scale of operations, scope, enabling domain investments, and delivery footprint. The group then classifies providers into leaders, major contenders, and emerging players. In addition, the PEAK Matrix designates eligible service providers with star performer status, based on relative year-over-year progress within the matrix.
“Life sciences firms are betting big on the realignment of their strategic focus and the expansion of service lines to cure their ailing margins. Technology is playing a central role in this construct,” said Abhishek Singh, practice director for Everest Group. “HCL continues to be a front-runner in this space backed by its domain expertise, delivery capabilities, and investments in value-chain focused offerings.”
Abhishek Shankar, vice president and head, life Sciences & Healthcare, HCL said,“Receiving this recognition for the third year in a row highlights our focus on delivering disruptive solutions and propositions that can help our clients in their digital transformation journey. It reinforces our commitment to drive member centricity, provide real time insights, measurable outcomes and personalized experience with a promise of lifetime of care.”
HCL’s life sciences and healthcare practice is one of the fastest growing businesses for the company. Its life sciences ITO business revenue doubled over the past three years and represents nearly 11 percent of the company’s total revenue. HCL offers proprietary life sciences solutions in the areas of predictive analytics, pharmacovigilance, regulatory compliance, sales force enablement, spend management, clinical data management, mobility and social media. HCL also provides key infrastructure services such as helpdesk and datacenter services, and application services including application development & maintenance (ADM), enterprise resource planning (ERP) and package implementation for some of the top life sciences and healthcare companies across the world.
About HCL Technologies
HCL Technologies (hcltech.com) is a leading global IT services company working with clients in the areas that impact and redefine the core of their businesses. Since its emergence on global landscape after its IPO in 1999, HCL has focused on 'transformational outsourcing', underlined by innovation and value creation, offering an integrated portfolio of services including software-led IT solutions, remote infrastructure management, engineering and R&D services and Business services. HCL leverages its extensive global offshore infrastructure and network of offices in 31 countries to provide holistic, multi-service delivery in key industry verticals including Financial Services, Manufacturing, Consumer Services, Public Services and Healthcare & Life sciences. HCL takes pride in its philosophy of 'Employees First, Customers Second' which empowers its 105,571 transformers to create real value for the customers. HCL Technologies, along with its subsidiaries, had consolidated revenues of US$ 6.1 billion, as on 30th September 2015 (on LTM basis).
HCL Forward-looking Statements
Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward looking statements, including but not limited to the statements containing the words 'planned','expects','believes’, ’ strategy','opportunity','anticipates','hopes' or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, Business Process Outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost effective and timely manner, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward looking statements made herein will prove to be accurate, and issuance of such forward looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward looking statements made herein are based on information presently available to the management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.